U.S. biotech Moderna given $483M to test potential COVID-19 vaccine
Friday, April 17, 2020 - 09:04
in Health & Medicine
Federal officials said their goal is to have a vaccine available as quickly as possible, and preparing now for advanced stage clinical trials "could shave months" off the process.